Unilateral onycholysis in a patient taking erlotinib (Tarceva)
نویسندگان
چکیده
منابع مشابه
Unilateral onycholysis in a patient taking erlotinib (Tarceva).
Targeting epidermal growth factor receptor (EGFR)-mediated signalling pathways has become routine practice in the treatment of lung cancer. Erlotinib is an oral EGFR tyrosine kinase inhibitor, licensed for maintenance monotherapy treatment in patients with locally advanced or metastatic non-small cell lung cancer after first-line chemotherapy. The authors present the case of a 51-year-old patie...
متن کاملAcneiform rash during lung cancer therapy with erlotinib (Tarceva®)
Tyrosine kinase inhibitors are currently applied in the treatment of non-small cell lung cancer with overexpressed epidermal growth factor receptor (EGFR). Acneiform rash is the earliest and most characteristic side effect of EGFR inhibition. The incidence may be as high as 50-100% of cases. We report a case of a 47-year-old patient who developed acneiform rash after 1.5 weeks of treatment with...
متن کاملOnycholysis after chemotherapy in a patient with lymphoma.
A 38-year-old man, without previous history of disease, was diagnosed with stage IIIB high-grade T-cell non-Hodgkin's lymphoma. He initially received eight cycles of cyclophosphamide (1350 mg), doxorubicin (90 mg), vincristine (2 mg) and prednisone (100 mg/day for 5 days) ^ CHOP regimen ^ with good response. The patient was disease-free for 3 years, after which the disease relapsed and he was s...
متن کاملPartial removable prosthesis in a patient with unilateral maxillectomy: A case report
BACKGROUND AND AIM: Maxillofacial defects due to malignant or benign tumors or congenital defects often result in complications such as the impairment of facial aesthetic, mastication, speech, and swallowing. Remedy of these defects, especially in a dentate patient is an important challenge in prosthodontics. Maxillectomy can lead to severe anatomical changes f...
متن کاملAcute Generalized Exanthematous Pustulosis Induced by Erlotinib (Tarceva) with Superimposed Staphylococcus aureus Skin Infection in a Pancreatic Cancer Patient: A Case Report
Acute generalized exanthematous pustulosis (AGEP) is a rare acute reaction that is drug induced in 90% of the cases and characterized by a widespread, sterile pustular rash. Erlotinib, a small-molecule EGFR tyrosine kinase inhibitor, has been approved by the FDA for patients with pancreatic cancer and non-small cell lung cancer. Skin rash is a well-known side effect related with all EGFR blocki...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Case Reports
سال: 2011
ISSN: 1757-790X
DOI: 10.1136/bcr.04.2011.4157